Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pernix Theraptcs Cmn (PTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 42,084
  • Shares Outstanding, K 10,020
  • Annual Sales, $ 140,860 K
  • Annual Income, $ -169,590 K
  • 36-Month Beta 1.91
  • Price/Sales 0.28
  • Price/Cash Flow 0.00
  • Price/Book 0.00

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.08 +33.77%
on 03/29/17
4.99 -17.43%
on 04/21/17
-0.05 (-1.20%)
since 03/27/17
3-Month
2.26 +82.30%
on 02/03/17
4.99 -17.43%
on 04/21/17
+1.33 (+47.67%)
since 01/27/17
52-Week
1.83 +125.14%
on 12/28/16
13.90 -70.36%
on 05/02/16
-3.78 (-47.85%)
since 04/27/16

Most Recent Stories

More News
Rennova Health and Pernix Therapeutics Both Led In the Pharma Arena with Significant Share Price Jumps

NEW YORK, NY / ACCESSWIRE / April 24, 2017 / The healthcare industry is vital as it is a major source of medical innovation and crucial services. The arena boasts plenty of companies that are focused...

RNVA : 1.01 (-2.88%)
PTX : 4.09 (-2.62%)
Today's Research Reports on Biotech Stocks to Watch: Catalyst Biosciences and Pernix Therapeutics

NEW YORK, NY / ACCESSWIRE / March 30, 2017 / The markets weren't really what you would call bullish yesterday. Barring a few, most of the stocks seeing changes of as little as 0.2-0.5%, either in the green...

PTX : 4.09 (-2.62%)
CBIO : 4.96 (+2.90%)
Pernix Therapeutics Provides Update on Arbitration

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company with a focus on Pain and CNS conditions, today provided an update on the Company's arbitration with GlaxoSmithKline ("GSK")....

PTX : 4.09 (-2.62%)
Drug Makers Stocks on Investors' Radar -- Synergy Pharma, Novo Nordisk, Sucampo Pharma, and Pernix Therapeutics

Stock-Callers.com today evaluates the following Drug Manufacturers equities: Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), Novo Nordisk A/S (NYSE: NVO), Sucampo Pharmaceuticals Inc. (NASDAQ: SCMP), and...

SCMP : 10.05 (+1.52%)
PTX : 4.09 (-2.62%)
NVO : 38.75 (+3.72%)
SGYP : 4.31 (+0.94%)
Pernix Therapeutics Appoints Ken Pina as General Counsel and Chief Compliance Officer

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company with a focus on pain and CNS conditions, today announced the appointment of Ken Pina as Senior Vice President, General...

PTX : 4.09 (-2.62%)
Drug Makers Stocks Under Scanner -- Novo Nordisk, Synergy Pharma, Pernix Therapeutics, and Apricus Biosciences

Stock-Callers.com revisits the Drug Manufacturers industry, which is focused on the research, distribution, and marketing of pharmaceutical drug products. Companies in this space can greatly be affected...

PTX : 4.09 (-2.62%)
NVO : 38.75 (+3.72%)
APRI : 1.10 (-2.65%)
SGYP : 4.31 (+0.94%)
Pernix Therapeutics Appoints New Board Member

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company with a focus on Pain and CNS conditions, today announced the appointment of Gabriel Leung to its Board of Directors,...

PTX : 4.09 (-2.62%)
Pernix Therapeutics Reports Third Quarter 2016 Financial Results and Provides Business Update

Net Revenue Increased 13% Sequentially Over Second Quarter 2016

PTX : 4.09 (-2.62%)
Pernix Therapeutics Appoints Two Board Members

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company with a focus on Pain and CNS conditions, today announced the appointment of Graham G. Miao, Ph.D. and Dennis H. Langer,...

PTX : 4.09 (-2.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Pernix Therapeutics Holdings Inc., formerly known as Golf Trust of America, Inc., is a specialty pharmaceutical company focused on developing and commercializing pharmaceutical products to meet medical needs primarily in pediatrics. The Company's product families include Aldex, Pediatex, Z-Cof, Brovex,...

See More

Support & Resistance

2nd Resistance Point 4.44
1st Resistance Point 4.32
Last Price 4.09
1st Support Level 3.99
2nd Support Level 3.78

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.